## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `article_bundle` — **LLM article bundle** Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. - **article slug:** `tesamorelin-postherpetic` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system. - **read:** https://miscsubjects.com/api/articles/tesamorelin-postherpetic/bundle?format=markdown ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-postherpetic/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/topology - **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/voxels - **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/prompts - **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node. - **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/voxels - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.* --- # miscsubjects article bundle > Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest. ## MASTHEAD - **identity:** `tesamorelin-postherpetic` v2 · content_hash `3adac43ea6935063…` · thread_head genesis · 23 DIVs - **thesis (c1):** No human trials test tesamorelin specifically in postherpetic neuralgia. - c2 [human/active] Ongoing Phase 2 trial NCT03150511 tests tesamorelin after peripheral nerve injury repair for axonal regeneration and functional recovery. - c3 [preclinical/active] GH treatment in rats after sciatic nerve transection increased axon/Schwann cell density and improved functional measures. - c4 [mechanistic/active] GH/IGF-1 therapies show multi-modal effects on nerve regeneration and muscle preservation in peripheral nerve injury reviews. - **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes - **standing objections:** 0 open → https://miscsubjects.com/api/articles/tesamorelin-postherpetic/discourse - **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key - **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/discourse · https://miscsubjects.com/api/protocol ## Article - **slug:** `tesamorelin-postherpetic` - **title:** Tesamorelin for Postherpetic Neuralgia: Evidence Review - **url:** https://miscsubjects.com/a/tesamorelin-postherpetic - **register:** source_ledger - **updated:** 2026-07-17T02:42:25.507Z - **tags:** peptide, matrix ## Body ## What's breaking down Postherpetic neuralgia (PHN) follows shingles (herpes zoster) reactivation of varicella-zoster virus. Nerve damage occurs in affected dermatomes. Axons degenerate. Myelin sheaths suffer. Distal tissues lose innervation. Muscle atrophy can follow if reinnervation lags. Chronic pain persists because repair pathways fail to restore normal signaling. This is degeneration outrunning repair at the peripheral nerve level. ## Why Tesamorelin might help you Tesamorelin stimulates growth hormone release via the GH axis. If your postherpetic issue includes failed axonal regeneration or muscle atrophy from denervation, this layer matters. 1. GH and IGF-1 signaling support Schwann cell activity and axon growth in nerve injury models. 2. Therefore for you: If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain. 3. Reduced visceral fat is a separate documented effect but not directly tied to neural recovery here. ## How these fit together Single-compound focus. Tesamorelin maps to the GH axis / visceral fat layer. If your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile. - **Tesamorelin** → GH axis / visceral fat ## What the evidence actually shows No human trials test tesamorelin specifically in postherpetic neuralgia (preclinical|mechanistic). One ongoing Phase 2 trial (NCT03150511) evaluates tesamorelin after peripheral nerve injury repair in humans; outcomes include axonal regeneration via MRI/EMG and functional recovery. Results remain unpublished as of 2026 (human|ongoing). Animal studies show growth hormone improves sciatic nerve regeneration after transection in rats: increased axon and Schwann cell density, higher compound muscle action potential amplitude, and better treadmill performance (preclinical|animal). A 2016 review summarizes GH/IGF-1 effects on multiple tissues in peripheral nerve injury, including reduced muscle atrophy (preclinical|review). Tesamorelin reduces visceral adipose tissue in HIV patients per prior FDA data, but this does not address nerve repair (human|separate indication). ## What scientists say Researchers note GH-based therapies show multi-modal promise for peripheral nerve injuries through accelerated regeneration and atrophy limitation, distinct from single-pathway agents (mechanistic|review). They call for clinical translation but emphasize lack of approved indications for neuropathic pain syndromes like PHN. ## What people say on Reddit Scant discussion. One thread mentions thymosin peptides for potential nerve repair in PHN contexts; no direct tesamorelin reports (anecdotal|none). ## What people say on X No relevant posts identified linking tesamorelin to postherpetic neuralgia or shingles recovery (anecdotal|none). ## What we do not know Direct efficacy in PHN remains untested in humans. Optimal timing post-shingles, interaction with standard analgesics, and long-term nerve-specific outcomes lack data. Translation from traumatic nerve injury models to viral neuropathy is speculative. ## Safety and limits Tesamorelin carries documented effects on glucose metabolism and injection-site reactions from approved use. No PHN-specific safety data exist. Evidence base is early-stage for nerve applications overall. ## Claims (4) - **c3** [preclinical w=0.5] GH treatment in rats after sciatic nerve transection increased axon/Schwann cell density and improved functional measures. - who_claims: grok/grok-4.3 - sources: s3 - **c4** [mechanistic w=0.3] GH/IGF-1 therapies show multi-modal effects on nerve regeneration and muscle preservation in peripheral nerve injury reviews. - who_claims: grok/grok-4.3 - sources: s4 - **c2** [human w=0.8] Ongoing Phase 2 trial NCT03150511 tests tesamorelin after peripheral nerve injury repair for axonal regeneration and functional recovery. - who_claims: grok/grok-4.3 - sources: s2 - **c1** [preclinical w=0.5] No human trials test tesamorelin specifically in postherpetic neuralgia. - who_claims: grok/grok-4.3 - sources: s1 ## Voxel graph (4 atoms · 8 edges) - full graph: https://miscsubjects.com/api/articles/tesamorelin-postherpetic/voxels ## Article constitution - full: https://miscsubjects.com/api/articles/constitution ## Source ledger (4) - chain valid: yes · head: `9063649e77acdc09` ### s1 · clinical_trial · ok - title: Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury - url: https://clinicaltrials.gov/study/NCT03150511 - summary: Ongoing trial focused on PNI, not PHN. - quote: The aim of this clinical trial is to evaluate the efficacy of tesamorelin as a therapy for peripheral nerve injuries. - claim_ids: c1 - hash: `0bb8ee52ed180446` ### s2 · clinical_trial · ok - title: Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury - url: https://clinicaltrials.gov/study/NCT03150511 - summary: Details trial aims for nerve recovery. - quote: The investigators hypothesize that treatment with tesamorelin will result in faster and more substantial recovery of motor and sensory function following surgical repair of injured peripheral nerves. - claim_ids: c2 - hash: `5cf2d75bebd4cb6f` ### s3 · pubmed · ok - title: Growth hormone treatment enhances the functional recovery of sciatic nerves after transection and repair - url: https://pubmed.ncbi.nlm.nih.gov/22334173/ - summary: Rat study on GH for nerve repair. - quote: GH-treated rats showed increased cellularity at the lesion site together with more abundant immunoreactive axons and Schwann cells. - claim_ids: c3 - hash: `7a65c15798ff045d` ### s4 · pubmed · ok - title: Therapeutic augmentation of the growth hormone axis to enhance peripheral nerve regeneration - url: https://pubmed.ncbi.nlm.nih.gov/27192539/ - summary: Review of GH mechanisms in nerve injury. - quote: GH-based therapies carry great promise for the treatment of peripheral nerve injuries, given the multi-modal mechanism of action not seen with other experimental therapies. - claim_ids: c4 - hash: `9063649e77acdc09` ## Provenance (2 model passes) - chain valid: yes · head: `bc4c6e4e64b228f9` - write · grok/grok-4.3 · 2026-06-29T23:15 · hash `6043c17c1a0e` - voxel_divide · owner · 2026-07-17T02:42 · hash `bc4c6e4e64b2` ## Question graph - questions: 0 · evidence ingests: 0 ## LLM manifest — how to communicate with this ledger - system map: https://miscsubjects.com/api/articles/system-map?format=markdown - topology (ranked): https://miscsubjects.com/api/articles/tesamorelin-postherpetic/topology - ingest: POST https://miscsubjects.com/api/protocol/ingest - claim: POST https://miscsubjects.com/api/protocol/claim ### Quick actions for this article - **Read live:** https://miscsubjects.com/api/articles/tesamorelin-postherpetic/topology - **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"tesamorelin-postherpetic","question":"..."}` - **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest tesamorelin-postherpetic|your evidence` - **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim tesamorelin-postherpetic|tier|assertion` - **iMessage ask:** `tesamorelin-postherpetic|your question` - **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown --- ## §SELF — miscsubjects portable reference **Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next. **This widget:** `system_map` — **System map** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **article slug:** `tesamorelin-postherpetic` - **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest - **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context. - **read:** https://miscsubjects.com/api/articles/system-map ### Logical proof (verify each step) 1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution 2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/tesamorelin-postherpetic/sources 3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol 4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow 5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex 6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map ### Related features (explains other parts of the system) - **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution - **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest - **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip - **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip - **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/tesamorelin-postherpetic/bundle?format=markdown - **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown ### Full index - JSON: https://miscsubjects.com/api/articles/system-map - Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown ### §STRUCTURE This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure ### §INTEGRITY Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you. ### §GAUNTLET Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted. *Not medical advice. Tier-honest. Cite claim/source ids.*